Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1999
11/11/1999WO1999043354A3 Method for treating painful conditions of the anal region and compositions therefor
11/11/1999WO1999042574B1 Sequences of an ih ionic channel and the use thereof
11/11/1999CA2331844A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999CA2331070A1 New use
11/11/1999CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999CA2330568A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328108A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/11/1999CA2327355A1 Human receptor molecules
11/11/1999CA2271837A1 1,2,5,-trisubstituted 1,2,-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955301A2 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylchloline receptors
11/10/1999EP0955296A2 Tertiary alkyl functionalized piperazine derivatives
11/10/1999EP0955295A1 Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl) piperazines
11/10/1999EP0954532A1 Novel human apoptosis regulator
11/10/1999EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999EP0954529A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
11/10/1999EP0954521A1 4- (thien-3-yl)methyl] imidazole derivatives having alpha2-adrenoceptor agonistic activity
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/10/1999EP0954337A1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/10/1999EP0954317A2 Use of 7 apha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
11/10/1999EP0954311A1 Use of 1- 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl) ethane for preparing medicines for the treatment of cerebral and neuronal disorders
11/10/1999EP0954303A2 Methods of treating mental diseases, inflammation and pain
11/10/1999EP0954302A1 Therapeutic methods and compositions involving isoflavones
11/10/1999EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999CN1234799A 1,4-disubstituted piperazines
11/10/1999CN1234797A N-substituted azaheterocyclic compound
11/10/1999CN1234795A Heterocyclic esters and amides chemical compounds
11/10/1999CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999CN1234738A 奥氮平二水合物d Olanzapine dihydrate d
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1046281C Pharmacologically active enantiomers and preparation method thereof
11/10/1999CN1046273C 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-diazoles useful as memory enhancers
11/09/1999US5981767 Method of producing dry thioctic acid
11/09/1999US5981755 Tachykinin antagonists
11/09/1999US5981754 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity
11/09/1999US5981708 Rodent polypeptide which is an autocrine growth factor; for augmenting growth of hematopoeitic stem cells; for antitumor agents to control tumor cell growth
11/09/1999US5981594 Method of treatment for diabetic neuropathy
11/09/1999US5981589 Copolymer-1 improvements in compositions of copolymers
11/09/1999US5981572 Treatment of disorders which arise from a disturbed functioning of systems which are regulated by melatonin; in particular in the treatment of chronobiological disorders, especially in the elderly
11/09/1999US5981571 Benzodioxa alkylene ethers as melatonergic agents
11/09/1999US5981560 1,2,4-triazole fungicides
11/09/1999US5981553 Heterocycle substituted propenoic acid derivatives as NMDA antagonist
11/09/1999US5981545 N-linked azabicyclic heterocycles useful for treating dementia
11/09/1999US5981544 For treatment of diseases involving an alteration in the venous function and/or inflammatory edema
11/09/1999US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders
11/09/1999US5981539 Piperidine compounds as calcium channel blockers
11/09/1999US5981535 Substituted xanthines and their use in the treatment of cerebrovascular disorders and other diseases
11/09/1999US5981531 For inhibiting platelet aggregation
11/09/1999US5981529 Substituted indolylpropyl-piperazine derivatives as 5-HT1D α agonists
11/09/1999US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999US5981524 Substituted 9-alkyladenines
11/09/1999US5981513 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/09/1999US5981511 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
11/09/1999US5981508 Facilitation of repair of neural injury with CM101/GBS toxin
11/09/1999US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981480 Pantropic neurotrophic factors
11/09/1999US5981475 Treatment for sensitive teeth
11/09/1999US5981246 Nucleic acids encoding EPH-like receptor protein tyrosine kinases
11/09/1999US5981245 Polypeptide kinase coded by a nucleic acid sequence; antibody development; for modulating kinase receptor activation and detecting receptor ligands
11/09/1999US5981222 Mammalian polynucleotide encoding protein factor; for disease prevention and treatment
11/09/1999US5981195 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors
11/09/1999US5981168 Method and composition for modulating amyloidosis
11/09/1999US5981165 Exogenous activation and expression of tyrosine hydroxylase in neural cells; culturing mammalian cells of central nervous system; treatment for parkinson's disease and other nervous system disorders
11/09/1999CA2177780C New arylalkyl(thio)carboxamide compounds, their preparation processes and the pharmaceutical compositions that contain them
11/06/1999CA2236989A1 Novel therapy for treatment of lysosomal storage disease
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055867A1 Delayed rectifier potassium channel subunit
11/04/1999WO1999055859A2 Cd40-interacting and traf-interacting proteins
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055699A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders
11/04/1999WO1999055698A1 Paroxetine ascorbate
11/04/1999WO1999055697A1 Serotonergic agents
11/04/1999WO1999055695A1 Indolyl derivatives as serotonergic agents
11/04/1999WO1999055694A1 Indolyl derivatives as serotonergic agents
11/04/1999WO1999055686A2 Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds
11/04/1999WO1999055682A1 Methods of identifying and using hla binding compounds as hla-agonists and antagonists
11/04/1999WO1999055680A1 Aryl fused azapolycyclic compounds
11/04/1999WO1999055678A1 Quinoline derivatives
11/04/1999WO1999055672A2 Antipsychotic indolyl derivatives
11/04/1999WO1999055667A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
11/04/1999WO1999055388A1 Substituted porphyrins
11/04/1999WO1999055371A1 Solution containing nicotine
11/04/1999WO1999055359A1 Compositions and methods for extending the action of clostridial neurotoxin
11/04/1999WO1999055338A1 Treatment of depression and pharmaceutical preparations therefor
11/04/1999WO1999055336A1 Riluzole and levodopa combinations for treating parkinson's disease
11/04/1999WO1999055321A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999WO1999055159A1 Serotonin potentiation by oleamide analogs
11/04/1999WO1999047131A3 Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor
11/04/1999WO1999046381A3 Human fgf gene and gene expression products
11/04/1999WO1999031074A3 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
11/04/1999WO1998027113A9 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
1 ... 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 ... 1833